BIOFILCHEMPharmaceuticals
Biofil Chemicals & Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹25.79
-4.48%
Current P/E21.13xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E124.1x83.0% below avg
✅
33.5% Discount to Industry
BIOFILCHEM P/E 21.13x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.44 | ₹57 | 130.6x |
| 2023 | ₹0.34 | ₹54 | 159.3x |
| 2022 | ₹0.44 | ₹55 | 125.5x |
| 2021 | ₹0.77 | ₹62 | 81x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Biofil Chemicals & Pharmaceuticals Ltd Valuation
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) currently trades at 21.13x earnings. The Pharmaceuticals sector average PE is 31.77x. BIOFILCHEM is trading at a discount to peers — may indicate relative value. Historically, BIOFILCHEM has traded at an average PE of 124.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
3.03%
Dividend Yield
0.00%
More on Biofil Chemicals & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.